Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delong Liu

Showing results (31-40 of 287) with videos related to

Pageof 29
Sort By:
Journal of Hematology & Oncology|June 7, 2026
Novel BTK inhibitors and degraders for relapsed/refractory CLL/SLL: latest updates from ASH 2025 annual meetingPritika Sharma, Heng Jiang, Delong Liu
Brazilian Journal of Otorhinolaryngology|July 5, 2024
Comprehensive analysis and treatment of intraoral thyroglossal duct cysts with intraoperative techniques: a 7-case series review in a tertiary care centerBo Li, Cuiping She, Delong Liu
Journal of Hematology & Oncology|June 16, 2026
Luspatercept and imetelstat for myelodysplastic syndrome: updates from ASH 2025 annual meetingYagya Ahlawat, Heng Jiang, Delong Liu
Journal of Hematology & Oncology|March 10, 2016
Acalabrutinib (ACP-196): a selective second-generation BTK inhibitorJingjing Wu, Mingzhi Zhang, Delong Liu
Journal of Hematology & Oncology|October 24, 2017
Clinical trials of CAR-T cells in ChinaBingshan Liu, Yongping Song, Delong Liu
Organic Letters|February 18, 2017
Iridium-Catalyzed Asymmetric Hydrogenation of β,γ-Unsaturated γ-Lactams: Scope and Mechanistic StudiesQianjia Yuan, Delong Liu, Wanbin Zhang
Experimental Hematology & Oncology|November 12, 2019
Recent advances on blinatumomab for acute lymphoblastic leukemiaJuanjuan Zhao, Yongping Song, Delong Liu
Journal of Hematology & Oncology|December 3, 2017
Recent development in clinical applications of PD-1 and PD-L1 antibodies for cancer immunotherapyBingshan Liu, Yongping Song, Delong Liu
Organic Letters|March 28, 2017
Synthesis of Chiral γ-Lactams via in Situ Elimination/Iridium-Catalyzed Asymmetric Hydrogenation of Racemic γ-Hydroxy γ-LactamsQianjia Yuan, Delong Liu, Wanbin Zhang
Journal of Hematology & Oncology|May 19, 2017
Clinical applications of PD-L1 bioassays for cancer immunotherapyDelong Liu, Shuhang Wang, Wendy Bindeman
Pageof 29

Showing results (31-40 of 287) with videos related to

Sort By:
Pageof 29
Journal of Hematology & Oncology|June 7, 2026
Novel BTK inhibitors and degraders for relapsed/refractory CLL/SLL: latest updates from ASH 2025 annual meetingPritika Sharma, Heng Jiang, Delong Liu
Brazilian Journal of Otorhinolaryngology|July 5, 2024
Comprehensive analysis and treatment of intraoral thyroglossal duct cysts with intraoperative techniques: a 7-case series review in a tertiary care centerBo Li, Cuiping She, Delong Liu
Journal of Hematology & Oncology|June 16, 2026
Luspatercept and imetelstat for myelodysplastic syndrome: updates from ASH 2025 annual meetingYagya Ahlawat, Heng Jiang, Delong Liu
Journal of Hematology & Oncology|March 10, 2016
Acalabrutinib (ACP-196): a selective second-generation BTK inhibitorJingjing Wu, Mingzhi Zhang, Delong Liu
Journal of Hematology & Oncology|October 24, 2017
Clinical trials of CAR-T cells in ChinaBingshan Liu, Yongping Song, Delong Liu
Organic Letters|February 18, 2017
Iridium-Catalyzed Asymmetric Hydrogenation of β,γ-Unsaturated γ-Lactams: Scope and Mechanistic StudiesQianjia Yuan, Delong Liu, Wanbin Zhang
Experimental Hematology & Oncology|November 12, 2019
Recent advances on blinatumomab for acute lymphoblastic leukemiaJuanjuan Zhao, Yongping Song, Delong Liu
Journal of Hematology & Oncology|December 3, 2017
Recent development in clinical applications of PD-1 and PD-L1 antibodies for cancer immunotherapyBingshan Liu, Yongping Song, Delong Liu
Organic Letters|March 28, 2017
Synthesis of Chiral γ-Lactams via in Situ Elimination/Iridium-Catalyzed Asymmetric Hydrogenation of Racemic γ-Hydroxy γ-LactamsQianjia Yuan, Delong Liu, Wanbin Zhang
Journal of Hematology & Oncology|May 19, 2017
Clinical applications of PD-L1 bioassays for cancer immunotherapyDelong Liu, Shuhang Wang, Wendy Bindeman
Pageof 29